Press Release | April 13, 2023
Caris Life Sciences and Flare Therapeutics Announce Strategic Preferred Portfolio Partnership to Advance Flare’s Precision Oncology Pipeline
Read More
News | March 26, 2023
Investing long-term in the cell & gene therapies of the future
Read More
News | March 22, 2023
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Read More
Press Release | March 16, 2023
Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors
Read More
